nach oben

25.04.2024 | Original Article

Clinical and radiographic characteristics of patients with non-functioning pituitary adenomas categorized according to their serum prolactin concentration: novel predictors of postoperative transient diabetes insipidus following surgery

verfasst von: Kiyohiko Sakata, Aya Hashimoto, Nobuyuki Takeshige, Kimihiko Orito, Ayako Nagayama, Kenji Ashida, Masatoshi Nomura, Motohiro Morioka

Erschienen in: Endocrine

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Non-functioning pituitary adenomas (NFPAs) are often associated with hyperprolactinemia, which is known as the “stalk effect”. However, the relationships between hyperprolactinemia and the radiographic characteristics of the tumor that affects the pituitary stalk have not been well characterized. We aimed to identify the differences in the clinical and radiographic characteristics of patients with NFPA, with and without hyperprolactinemia.

Methods

We enrolled 107 patients with NFPA and allocated them to hyperprolactinemia and non-hyperprolactinemia groups using two different cut-off values: (1) the upper limit of the normal reference range, adjusted for sex and menopausal status, and (2) the upper quartile across the cohort, and compared their clinical and radiographic characteristics. These analyses were conducted to clarify the relationship between the “stalk effect” and the postoperative change in antidiuretic hormone secretion.

Results

The specific radiographic characteristics of the patients included the presence of a cystic or hemorrhagic tumor and the presence of pituitary stalk deviation, which were more frequent in the patients with hyperprolactinemia. Interestingly, the incidence of postoperative transient diabetes insipidus was statistically significantly higher in the hyperprolactinemia group (≥40 ng/mL) and in the group with radiologic evidence of stalk deviation, which were shown to be independent risk factors on multivariate analysis.

Conclusion

The presence of a “stalk effect” was associated with a higher risk of postoperative transient diabetes insipidus, reflecting perioperative pituitary stalk dysfunction following NFPA surgery, especially in patients with serum prolactin concentrations ≥40 ng/mL and radiologic evidence of stalk deviation.

M.B.S. Lopes, Pathology of prolactinomas: any predictive value? Pituitary 23, 3–8 (2020). https://doi.org/10.1007/s11102-019-00997-1CrossRefPubMed

G. Ntali, J.A. Wass, Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas. Pituitary 21, 111–118 (2018). https://doi.org/10.1007/s11102-018-0869-3CrossRefPubMed

N. Ben-Jonathan, R. Hnasko, Dopamine as a prolactin (PRL) inhibitor. Endocr. Rev. 22, 724–763 (2001). https://doi.org/10.1210/edrv.22.6.0451CrossRefPubMed

J. Chahal, J. Schlechte, Hyperprolactinemia. Pituitary 11, 141–146 (2008). https://doi.org/10.1007/s11102-008-0107-5CrossRefPubMed

I. Samperi, K. Lithgow, N. Karavitaki, Hyperprolactinemia. J. Clin. Med. 8, 2203 (2019). https://doi.org/10.3390/jcm8122203CrossRefPubMedPubMedCentral

L. Vilar, C.F. Vilar, R. Lyra, M.D.C. Freitas, Pitfalls in the diagnostic evaluation of hyperprolactinemia. Neuroendocrinology 109, 7–19 (2019). https://doi.org/10.1159/000499694CrossRefPubMed

S. Melmed, F.F. Casanueva, A.R. Hoffman, D.L. Kleinberg, V.M. Montori, J.A. Schlechte, J.A. Wass, Endocrine Society: Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96, 273–288 (2011). https://doi.org/10.1210/jc.2010-1692CrossRefPubMed

S. Petersenn, M. Fleseriu, F.F. Casanueva, A. Giustina, N. Biermasz, B.M.K. Biller, M. Bronstein, P. Chanson, H. Fukuoka, M. Gadelha, Y. Greenman, M. Gurnell, K.K.Y. Ho, J. Honegger, A.G. Ioachimescu, U.B. Kaiser, N. Karavitaki, L. Katznelson, M. Lodish, D. Maiter, H.J. Marcus, A. McCormack, M. Molitch, C.A. Muir, S. Neggers, A.M. Pereira, R. Pivonello, K. Post, G. Raverot, R. Salvatori, S.L. Samson, I. Shimon, J. Spencer-Segal, G. Vila, J. Wass, S. Melmed, Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat. Rev. Endocrinol. 19, 722–740 (2023). https://doi.org/10.1038/s41574-023-00886-5CrossRefPubMed

M. Fleseriu, M.E. Bodach, L.M. Tumialan, V. Bonert, N.M. Oyesiku, C.G. Patil, Z. Litvack, M.K. Aghi, G. Zada, Congress of neurosurgical surgeons systematic review and evidence-based guideline for pretreatment endocrine evaluation of patients with nonfunctioning pituitary adenomas. Neurosurgery 79, E527–E529 (2016). https://doi.org/10.1227/NEU.0000000000001387CrossRefPubMed

10.

F. Zhang, Y. Huang, C. Ding, G. Huang, S. Wang, The prevalence of hyperprolactinemia in non-functioning pituitary macroadenomas. Int. J. Clin. Exp. Med 8, 18990–18997 (2015)PubMedPubMedCentral

11.

F. de Vries, D.J. Lobatto, M.J.T. Verstegen, W.R. van Furth, A.M. Pereira, N.R. Biermasz, Postoperative diabetes insipidus: how to define and grade this complication? Pituitary 24, 284–291 (2021). https://doi.org/10.1007/s11102-020-01083-7CrossRefPubMed

12.

E.K. Brooks, W.J. Inder, Disorders of salt and water balance after pituitary surgery. J. Clin. Endocrinol. Metab. 108, 198–208 (2022). https://doi.org/10.1210/clinem/dgac622CrossRefPubMedPubMedCentral

13.

S.S.M. Anwar, K. Hilal, A. Khan, A. Ahmad, Magnetic resonance imaging grading of pituitary macroadenoma – SIPAP classification revised. Eur. J. Radiol. Open. 10, 100486 (2023). https://doi.org/10.1016/j.ejro.2023.100486CrossRefPubMedPubMedCentral

14.

B. Cabuk, I. Anik, S. Kokturk, S. Ceylan, S. Ceylan, Anatomic and histologic features of diaphragma sellae that effects the suprasellar extension. J. Clin. Neurosci. 71, 234–244 (2020). https://doi.org/10.1016/j.jcon.2019.11.014CrossRefPubMed

15.

S. Gulsen, A.H. Dinc, M. Unal, N. Cantürk, N. Altinors, Characterization of the anatomic location of the pituitary stalk and its relationship to the dorsum sellae, tuberculum sellae and chiasmatic cistern. J. Korean Neurosurg. Soc. 47, 169–173 (2010). https://doi.org/10.3340/jkns.2010.47.3.169CrossRefPubMedPubMedCentral

16.

E. Knosp, E. Steiner, K. Kitz, C. Matula, Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33, 610–617 (1993). https://doi.org/10.1227/00006123-199310000-00008. discussion 617-618CrossRefPubMed

17.

L. Lyu, S. Yin, Y. Hu, C. Chen, Y. Jiang, Y. Yu, W. Ma, Z. Wang, S. Jiang, P. Zhou, Hyperprolactinemia in clinical non-functional pituitary macroadenomas: A STROBE-compliant study. Medicine 99, e22673 (2020). https://doi.org/10.1097/M.D.0000000000022673CrossRefPubMedPubMedCentral

18.

S.S. Park, J.H. Kim, Y.H. Kim, J.H. Lee, Y.S. Dho, C.S. Shin, Clinical and radiographic characteristics related to hyperprolactinemia in nonfunctioning pituitary adenomas. World Neurosurg. 119, e1035–e1040 (2018). https://doi.org/10.1016/j.wneu.2018.08.068CrossRefPubMed

19.

M. Bergsneider, L. Mirsadraei, W.H. Yong, N. Salamon, M. Linetsky, M.B. Wang, D.L. McArthur, A.P. Heaney, The pituitary stalk effect: is it a passing phenomenon? J. Neurooncol. 117, 477–484 (2014). https://doi.org/10.1007/s11060-014-1386-5CrossRefPubMed

20.

A. Kruse, J. Astrup, C. Gyldensted, G.E. Cold, Hyperprolactinaemia in patients with pituitary adenomas. The pituitary stalk compression syndrome. Br. J. Neurosurg. 9, 453–457 (1995). https://doi.org/10.1080/02688699550041089CrossRefPubMed

21.

M.V. Smith, E.R. Laws Jr, Magnetic resonance imaging measurements of pituitary stalk compression and deviation in patients with nonprolactin-secreting intrasellar and parasellar tumors: lack of correlation with serum prolactin levels. Neurosurgery 34, 834–839 (1994). https://doi.org/10.1227/00006123-199405000-00007. discussion 839CrossRefPubMed

22.

B.M. Arafah, D. Prunty, J. Ybarra, M.L. Hlavin, W.R. Selman, The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. J. Clin. Endocrinol. Metab. 85, 1789–1793 (2000). https://doi.org/10.1210/jcem.85.5.6611CrossRefPubMed

23.

P.D. Lees, J.D. Pickard, Hyperprolactinemia intrasellar pituitary tissue pressure, and the pituitary stalk compression syndrome. J. Neurosurg. 67, 192–196 (1987). https://doi.org/10.3171/jns.1987.67.2.0192CrossRefPubMed

24.

G. Hildebrandt, H.W. Mueller, H. Stracke, Z.M. Rap, N. Klung, Different types of postoperative diabetes insipidus and the relation to basal and stimulated serum prolactin levels in patients with hypothalamo-hypophyseal tumorous lesions. Acta Neurochir. 104, 110–120 (1990). https://doi.org/10.1007/BF01842828CrossRefPubMed

25.

A.M. Ajlan, S.B. Abdulqader, A.S. Achrol, Y. Aljamaan, A.H. Feroze, L. Katznelson, G.R. Harsh, Diabetes insipidus following endoscopic transsphenoidal surgery for pituitary adenoma. J. Neurol. Surg. B. Skull Base. 79, 117–122 (2018). https://doi.org/10.1055/s-0037-1604363CrossRefPubMed

26.

M. Araujo-Castro, F. Mariño-Sánchez, A. Acitores Cancela, A. García Fernández, S. García Duque, V. Rodríguez Berrocal, Is it possible to predict the development of diabetes insipidus after pituitary surgery? Study of 241 endoscopic transsphenoidal pituitary surgeries. J. Endocrinol. Invest 44, 1457–1464 (2021). https://doi.org/10.1007/s40618-020-01448-6CrossRefPubMed

27.

W.T. Burke, D.J. Cote, D.L. Penn, S. Luliano, K. McMillen, E.R. Laws, Diabetes insipidus after endoscopic transsphenoidal surgery. Neurosurgery 87, 949–955 (2020). https://doi.org/10.1093/neuros/nyaa148CrossRefPubMed

28.

J. Hensen, A.H.R. Fahlbusch, M. Meyer, M. Boehnert, M. Buchfelder, Prevalence, predictors and patterns of postoperative polyuria and hyponatraemia in the immediate course after transsphenoidal surgery for pituitary adenomas. Clin. Endocrinol. 50, 431–439 (1999). https://doi.org/10.1046/j.1365-2265.1999.00666.xCrossRef

29.

R.S. Joshi, M.P. Pereira, R.C. Osorio, T. Oh, A.F. Haddad, K.M. Pereira, K.C. Donohue, Z. Peeran, S. Sundhir, S. Jain, A. Beniwal, A. Chandra, S.J. Han, J.D. Rolston, P.V. Theodosopoulos, S. Kunwar, L.S. Blevins Jr, M.K. Aghi, Identifying risk factors for postoperative diabetes insipidus in more than 2500 patients undergoidng transsphenoidal surgery: a single-institution experience. J. Neurosurg. 137, 647–657 (2022). https://doi.org/10.3171/2021.11,JSN211260CrossRef

30.

E.L. Sorba, V.E. Staartjes, S. Voglis, L. Tosic, G. Brandi, O. Tschopp, C. Serra, L. Regli, Diabetes insipidus and syndrome of inappropriate antidiuresis (SIADH) after pituitary surgery: incidence and risk factors. Neurosurg. Rev. 44, 1503–1511 (2021). https://doi.org/10.1007/s10143-020-01340-0CrossRefPubMed

31.

M.E. Yasuda, D. Renedo, S. Sosa, K. Danilowicz, R. Recalde, R. Zaninovich, G. Abbati, A. Cervio, S. Giovannini, J. Villalonga, L. Ulloque-Caamaño, K. Reddy, M. Socolovsky, A. Campero, Risk factors related to transient diabetes insipidus development following transsphenoidal pituitary adenoma resection: A multicentric study. World Neurosurg. 175, e636–e643 (2023). https://doi.org/10.1016/j.wneu.2023.03.150CrossRefPubMed

32.

P. Nayak, A.S. Montaser, J. Hu, D.M. Prevedello, L.S. Kirschner, L. Ghalib, Predictors of postoperative diabetes insipidus following endoscopic resection of pituitary adenomas. J. Endocr. Soc. 2, 1010–1019 (2018). https://doi.org/10.1210/js.2018-00121CrossRefPubMedPubMedCentral

33.

M. Schreckinger, B. Walker, J. Knepper, M. Hornyak, D. Hong, J.-M. Kim, A. Folbe, M. Guthikonda, S. Mittal, N.J. Szerlip, Post-operative diabetes insipidus after endoscopic transsphenoidal surgery. Pituitary 16, 445–451 (2013). https://doi.org/10.1007/s11102-012-0453-1CrossRefPubMed

34.

N. Alidaei, G. Sharifi, Z. Davoudi, Importance of intraoperative factors in postoperative arginine vasopressin deficiency after pituitary adenoma surgery. Endocr. Pract. 30, 253–258 (2024). https://doi.org/10.1016/j.eprac.2023.12.003CrossRefPubMed

35.

E.C. Nemergut, Z. Zuo, J.A. Jane Jr, E.R. Laws Jr, Predictors of diabetes insipidus after transsphenoidal surgery: a review of 881 patients. J. Neurosurg. 103, 448–454 (2005). https://doi.org/10.3171/jns.2005.103.3.0448CrossRefPubMed

36.

D.G. Sigounas, J.L. Sharpless, D.M.L. Cheng, T.G. Johnson, B.A. Senior, M.G. Ewend, Predictors and incidence of central diabetes insipidus after endoscopic pituitary surgery. Neurosurgery 62, 71–78 (2008). https://doi.org/10.1227/01.NEU.0000311063.10745.D8CrossRefPubMed

37.

M. Tanji, Y. Mineharu, M. Kikuchi, T. Nakagawa, T. Sakamoto, M. Yamashita, M. Matsunaga, F. Kuwata, Y. Kitada, Y. Terada, Y. Arakawa, K. Yoshida, H. Kataoka, S. Miyamoto, Intraoperative cerebrospinal fluid leak graded by Esposito grade is a predictor for diabetes insipidus after endoscopic endonasal pituitary adenoma resection. World Neurosurg. 158, e896–e902 (2022). https://doi.org/10.1016/j.wneu.2021.11.090CrossRefPubMed

38.

O. Alexopoulou, V. Everard, M. Etoa, E. Fomekong, S. Gaillard, F. Parker, C. Raftopoulos, P. Chanson, D. Maiter, Outcome of pituitary hormone deficits after surgical treatment of nonfunctioning pituitary macroadenomas. Endocrine 73, 166–176 (2021). https://doi.org/10.1007/s12020-021-02701-5CrossRefPubMed

39.

A.N. Hoang, B.G. McGahan, S. Cua, S.T. Magill, P. Nayak, A.S. Montaser, L. Ghalib, L.M. Prevedello, D.A. Hardesty, R.L. Carrau, D.M. Prevedello, Pituitary stalk stretch predicts postoperative diabetes insipidus after pituitary macroadenoma transsphenoidal resection. Oper. Neurosurg. 24, 248–255 (2023). https://doi.org/10.1227/ons.0000000000000501CrossRef

40.

K. Lin, K. Fan, S. Mu, S. Wang, Change in cephalocaudal tumor cavity diameter after transsphenoidal surgery is a predictor of diabetes insipidus in pituitary adenoma. Eur. J. Med. Res. 27, 72 (2022). https://doi.org/10.1186/s40001-022-00700-4CrossRefPubMedPubMedCentral

41.

J. Ma, P. Gooderham, R. Akagami, S. Makarenko, Correlation of pituitary descent and diabetes insipidus after transsphenoidal pituitary macroadenoma resection. Neurosurgery 92, 1269–1275 (2023). https://doi.org/10.1227/neu.0000000000002360CrossRefPubMed

42.

H. Oh, H. Cheun, Y.J. Kim, H.K. Yoon, H. Kang, H.C. Lee, H.P. Park, J.H. Kim, Y.H. Kim, Cephalocaudal tumor diameter is a predictor of diabetes insipidus after endoscopic transsphenoidal surgery for non-functioning pituitary adenoma. Pituitary 24, 303–311 (2021). https://doi.org/10.1007/s11102-020-01108-1CrossRefPubMed

43.

L. Xue, J. Wu, J. Chen, Y. Yang, Change in the pituitary stalk deviation angle after transsphenoidal surgery can predict the development of diabetes insipidus for pituitary adenomas. Endocr. Connect. 11, e220187 (2022). https://doi.org/10.1530/EC-22-0187CrossRefPubMedPubMedCentral

44.

B.R. Olson, J. Gumowski, D. Rubino, E.H. Oldfield, Pathophysiology of hyponatoremia after transsphenoidal pituitary surgery. J. Neurosurg. 87, 499–507 (1997). https://doi.org/10.3171/jns.1997.87.4.0499CrossRefPubMed

45.

K. Takano, [Endocrine diseases: progress in diagnosis and treatments. Topics: I. Anterior lobes of the pituitary; 3. Diagnosis and treatment of prolactinoma] Nihon. Naika. Gakkai. Zasshi 103, 841–848 (2014). https://doi.org/10.2169/naika.103.841CrossRef

46.

B.M. Arafah, K.E. Nekl, R.S. Gold, W.R. Selman, Dynamics of prolactin secretion in patients with hypopituitarism and pituitary macroadenomas. J. Clin. Endocrinol. Metab. 80, 3507–3512 (1995). https://doi.org/10.1210/jcem.80.12.8530591CrossRefPubMed

47.

H.A. Zaidi, D.J. Cote, J.P. Castlen, W.T. Burke, Y.H. Liu, T.R. Smith, E.R. Laws Jr, Time course of resolution of hyperprolactinemia after transsphenoidal surgery among patients presenting with pituitary stalk compression. World Neurosurg. 97, 2–7 (2017). https://doi.org/10.1016/j.wneu.2016.09.066CrossRefPubMed

Titel: Clinical and radiographic characteristics of patients with non-functioning pituitary adenomas categorized according to their serum prolactin concentration: novel predictors of postoperative transient diabetes insipidus following surgery
verfasst von: Kiyohiko Sakata
Aya Hashimoto
Nobuyuki Takeshige
Kimihiko Orito
Ayako Nagayama
Kenji Ashida
Masatoshi Nomura
Motohiro Morioka
Publikationsdatum: 25.04.2024
Verlag: Springer US
Erschienen in: Endocrine
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-024-03835-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen